Healthcare >> CEO Interviews >> February 2, 2004
LLOYD M. SEGAL has been President and Chief Executive Officer of Caprion
Pharmaceuticals Inc. since 1998. He has presided over Caprion's growth
and key alliances. Mr. Segal previously served as President and CEO of
Advanced Bioconcept Ltd. from 1996 to 1998, and was a management
consultant with McKinsey & Co. from 1991 to 1996. He is a member of the
Board of Directors of SciQuest (NASDAQ:SQST) and a member of the Board
of Overseers of the School of Science, Brandeis University. He earned a
BA in Politics from Brandeis University and an MBA from Harvard Business
School. Profile
Mr. Segal: Caprion is an antibody-focused drug discovery company. Our
work is primarily proteomics-driven and targets novel protein targets on
the cell
